| Utility: Materials and methods for engineering cells and uses thereof in immuno-oncology Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 | 4 Jun 2019 | 11 Aug 2020 |
| Utility: COMPOSITIONS AND METHODS FOR TREATMENT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)-RELATED DISORDERS Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 | 15 Feb 2018 | 6 Aug 2020 |
| Utility: Materials and methods for engineering cells and uses thereof in immuno-oncology Filling date: 12 Sep 2025 Issue date: 4 Aug 2020 | 7 Jun 2019 | 4 Aug 2020 |
| Utility: Universal donor cells Filling date: 12 Sep 2025 Issue date: 28 Jul 2020 | 6 Sep 2019 | 28 Jul 2020 |
| Utility: ANTI-LIV1 IMMUNE CELL CANCER THERAPY Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 | 7 Nov 2019 | 23 Jul 2020 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 (SCA2) AND OTHER SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN (ATXN2) GENE RELATED CONDITIONS OR DISORDERS Filling date: 12 Sep 2025 Issue date: 9 Jul 2020 | 21 Feb 2018 | 9 Jul 2020 |
| Utility: Materials and methods for treatment of autosomal dominant retinitis pigmentosa Filling date: 12 Sep 2025 Issue date: 26 May 2020 | 21 Nov 2018 | 26 May 2020 |
| Utility: COMPOSITIONS AND METHODS FOR GENE EDITING Filling date: 12 Sep 2025 Issue date: 21 May 2020 | 21 Feb 2018 | 21 May 2020 |
| Utility: ANTI-PTK7 IMMUNE CELL CANCER THERAPY Filling date: 12 Sep 2025 Issue date: 7 May 2020 | 7 Nov 2019 | 7 May 2020 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF APOLIPOPROTEIN C3 (APOCIII)-RELATED DISORDERS Filling date: 12 Sep 2025 Issue date: 23 Apr 2020 | 29 Jun 2017 | 23 Apr 2020 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF MEROSIN-DEFICIENT COGENITAL MUSCULAR DYSTROPHY (MDCMD) AND OTHER LAMININ, ALPHA 2 (LAMA2) GENE RELATED CONDITIONS OR DISORDERS Filling date: 12 Sep 2025 Issue date: 26 Mar 2020 | 14 Feb 2018 | 26 Mar 2020 |
| Utility: UNIVERSAL DONOR CELLS Filling date: 12 Sep 2025 Issue date: 12 Mar 2020 | 6 Sep 2019 | 12 Mar 2020 |
| Utility: UNIVERSAL DONOR CELLS Filling date: 12 Sep 2025 Issue date: 12 Mar 2020 | 6 Sep 2019 | 12 Mar 2020 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (PH1) AND OTHER ALANINE-GLYOXYLATE AMINOTRANSFERASE (AGXT) GENE RELATED CONDITIONS OR DISORDERS Filling date: 12 Sep 2025 Issue date: 12 Mar 2020 | 21 Feb 2018 | 12 Mar 2020 |
| Utility: METHODS AND COMPOSITIONS FOR TREATING CANCER Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 | 10 May 2019 | 27 Feb 2020 |
| Utility: COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES Filling date: 12 Sep 2025 Issue date: 6 Feb 2020 | 28 Jun 2019 | 6 Feb 2020 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF EARLY ONSET PARKINSON'S DISEASE (PARK1) AND OTHER SYNUCLEIN, ALPHA (SNCA) GENE RELATED CONDITIONS OR DISORDERS Filling date: 12 Sep 2025 Issue date: 6 Feb 2020 | 16 Feb 2018 | 6 Feb 2020 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A Filling date: 12 Sep 2025 Issue date: 19 Dec 2019 | 7 Nov 2016 | 19 Dec 2019 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY Filling date: 12 Sep 2025 Issue date: 12 Dec 2019 | 28 Oct 2016 | 12 Dec 2019 |
| Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 | 6 Jun 2019 | 5 Dec 2019 |
| Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 | 4 Jun 2019 | 5 Dec 2019 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF DYSTROPHIC EPIDERMOLYSIS BULLOSA (DEB) AND OTHER COLLAGEN TYPE VII ALPHA 1 CHAIN (COL7A1) GENE RELATED CONDITIONS OR DISORDERS Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 | 14 Feb 2018 | 5 Dec 2019 |
| Utility: METHODS AND COMPOSITIONS FOR EFFICIENT GENE DELETION Filling date: 12 Sep 2025 Issue date: 28 Nov 2019 | 24 May 2019 | 28 Nov 2019 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER RELATED DISORDERS Filling date: 12 Sep 2025 Issue date: 31 Oct 2019 | 15 Jun 2017 | 31 Oct 2019 |
| Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 | 7 Jun 2019 | 17 Oct 2019 |
| Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 | 7 Jun 2019 | 17 Oct 2019 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 19 Sep 2019 | 5 Feb 2019 | 19 Sep 2019 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 22 Aug 2019 | 5 Feb 2019 | 22 Aug 2019 |
| Utility: MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS Filling date: 12 Sep 2025 Issue date: 25 Jul 2019 | 6 Jul 2017 | 25 Jul 2019 |
